Press "Enter" to skip to content

New patent for Pfizer drug LORBRENA

0
Copyright © DrugPatentWatch. Originally published at New patent for Pfizer drug LORBRENA

Annual Drug Patent Expirations for LORBRENA
Annual Drug Patent Expirations for LORBRENA

Lorbrena is a drug marketed by Pfizer and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.

This drug has sixty-nine patent family members in forty-seven countries.

The generic ingredient in LORBRENA is lorlatinib. One supplier is listed for this compound. Additional details are available on the lorlatinib profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Pfizer drug LORBRENA
Find your next blockbuster

Get accurate and timely intelligence — in just a few clicks

✓ Free trial

✓ No credit card

 

DrugPatentWatch - Make Better Decisions